(19)
(11) EP 1 299 530 A2

(12)

(88) Date of publication A3:
20.06.2002

(43) Date of publication:
09.04.2003 Bulletin 2003/15

(21) Application number: 01954662.1

(22) Date of filing: 12.07.2001
(51) International Patent Classification (IPC)7C12N 15/00
(86) International application number:
PCT/US0121/985
(87) International publication number:
WO 0200/4600 (17.01.2002 Gazette 2002/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.07.2000 US 218033 P
21.08.2000 US 226517 P

(71) Applicants:
  • SmithKline Beecham Corporation
    King of Prussia, PA 19406 (US)
  • Smithkline Beecham PLC
    Brentford,Middlesex TW8 9EP (GB)
  • GLAXO GROUP LIMITED
    Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • AGARWAL, Pankaj
    King of Prussia, PA 19406 (US)
  • COGSWELL, John, P.
    Research Triangle Park, NC 27709 (US)
  • LAI, Ying-Ta
    Upper Darby, PA 19082 (US)
  • MARTENSEN, Shelby, A.
    Research Triangle Park, NC 27709 (US)
  • RIZVI, Safia, K.
    Philadelphia, PA 19143 (US)
  • STRUM, Jay, C.
    Research Triangle Park, NC 27709 (US)
  • SMITH, Randall, F.
    Lafayette Hill, PA 19444 (US)
  • XIANG, Zhaoying
    Fort Lee, NJ 07024 (US)
  • XIE, Qing
    Horsham, PA 19044 (US)

(74) Representative: Giddings, Peter John, Dr. 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) NOVEL COMPOUNDS